Effectiveness of delayed epinephrine in anaphylaxis.
Hare
Nathaniel D
ND
Ballas
Zuhair K
ZK
D000369:Aged, 80 and over; D000707:Anaphylaxis / Q000188:drug therapy* / Q000503:physiopathology; D000925:Anticoagulants / Q000009:adverse effects; D052157:Aptamers, Nucleotide / Q000009:adverse effects; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D002318:Cardiovascular Diseases / Q000150:complications / Q000188:drug therapy; D004837:Epinephrine / Q000008:administration & dosage*; D005128:Eye Diseases / Q000188:drug therapy; D016027:Heart Transplantation; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D000925:Anticoagulants; D052157:Aptamers, Nucleotide; D001993:Bronchodilator Agents; C495058:pegaptanib; D006493:Heparin; D004837:Epinephrine